The U.S. Food and Drug Administration has issued a warning letter to a South Carolina drug company charging that it violated the same provisions of federal law that were violated by the company responsible for a deadly nationwide fungal meningitis outbreak.
The four-page letter charges that Medi-Fare Drug and Home Health Center was compounding drugs without patient-specific prescriptions and was acting as a drug manufacturer. The firm was cited for multiple other violations including allowing drugs to become adulterated.
Medi-Fare could not be reached for comment.
FDA spokeswoman Sara Clark-Lynn said the agency is taking targeted action aimed at compounding firms producing sterile drug products.
Continue reading here
No comments:
Post a Comment